(To whom it may concern),
I am contacting you in relation to a current national campaign to reduce drug related deaths in England. In light of the recent 32% rise in drug related deaths bringing the statistical data of those dying from overdose involving opioid substances in 2013 to a staggering 765 deaths, each one preventable.
Please find attached below a brief timeline of Naloxone from it’s inception up until present .
As you will see there are a number of periods where there has been open endorsement from a number of sources here in the UK. These endorsements have been made by:
Professor John Strang in the British Medical Journal (1996).
ACMD (Advisory Council for the Misuse of Drugs) (2000) (2012)
UK Clinical Guidelines (2007)
NTA (National Treatment Agency) (2007) (2009)
MRC (Medical Research Council) (2008)
The department of health chairperson Jane Ellison sent a letter, in July of last year, to the ACMD giving clear direction as to a date for commencement of National Naloxone program from October 2015….
This letter lays out a clear and direct plan of action which advocates for training and any other preparations to be supported ‘prior’ to the date given for roll out and was a direct result of the MHRA survey which returned an overwhelming show of support for the provision of Naloxone in the community.
I feel that a delay until October 2015 is irrational given the evidence of support given and believe that this delay warrants a judicial review based on the evidence collated globally and also from the National programs in both Scotland and Wales where take home programs have had a positive effect on th statistics surrounding drug related deaths. I also feel that this delay is a serious breach of human rights in that every human being has the right to access life saving medication and the right to live. This delay has the potential to interfere with the right to life and also the right to a family life.
Given the case that I hereby put forward for direct and immediate action towards implementation of Take Home Naloxone programs nationally. I would be grateful if you could reply to my concerns by:
A: Informing of what is currently happening locally to put this program in place
B: Informing me of the reasons for delay in implementing a local program.
I look forward to further correspondence with you regarding this issue.